Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.
- Conditions
- Ascendant Aortic Aneurysm
- Interventions
- Other: Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm
- Registration Number
- NCT03113539
- Lead Sponsor
- Université de Sherbrooke
- Brief Summary
We will demonstrate the validity of measurements with a low-dose, EKG-gated CT without contrast in the ascending aorta evaluation, compared with the current Angio-CT measurements.
- Detailed Description
The actual protocol used in aorta evaluation consist of two CT-scans on the same study. The first scan that detects calcifications is using parameters with low-dose current, non EKG-gated and without contrast. The second scan uses iodine-contrast, EKG-gating and higher current dose to obtain higher image quality of diagnostic value.
The study will optimize the first scan parameters and compare the measures of the aorta diameters from the standard protocol.
By modifying the first scan parameters, we would demonstrate that the follow-up of an aortic aneurysm can safely be made with lower radiation exposure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- 60 years old and more
- 85 bpm or less
- aortic material
- EKG gating not possible
- aorta pathology (thrombus, dissection)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Subjects awaiting for an aortic evaluation Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm Subjects already waiting for an aortic evaluation, either a first diagnostic scan or follow-up of a known aneurysm. Each subjects will have the two CT-scans on the same day.
- Primary Outcome Measures
Name Time Method Measures validity (aorta diameter in mm from scan images) 12 months Comparing aorta diameters from the two modalities.
- Secondary Outcome Measures
Name Time Method Radiation (in msev from scanner report) 12 months Comparing radiation exposure with the two modalities
Trial Locations
- Locations (1)
Sherbrooke University Hospital
🇨🇦Sherbrooke, Quebec, Canada